Personal identification

Full name
Maria de Jesus Almeida Rainha Perry da Câmara Saldanha Rocha

Author identifiers

Ciência ID


  1. Perry, MJ. Heterocyclic Targets in Advanced Organic Synthesis. India. 2011.
  2. Perry, MJ. Anticancer Therapeutics. United Kingdom. 2008.
  3. Francisco, A.P.; Perry, M.D.J.; Moreira, R.; Mendes, E.. Alkylating Agents. 2008.
Book chapter
  1. Perry, MJ. "Adittion to carbonyl compounds other than aldol reaction, Knorr Pyrazole Synthesis of Edaravone". United Kingdom: Royal Society of Chemistry, 2017.
  2. Perry, MJ. "Epoxidations, Stereoselective Epoxidation of Cholesterol by m-Chloroperoxybenzoic acid". 754. United Kingdom: Royal Society of Chemistry, 2017.
  3. Perry, MJ. "Wittig type reactions, Preparation of Nitrostilbenes by the Wittig reaction". 623. United Kingdom: Royal Society of Chemistry, 2017.
Journal article
  1. Marta Clariano; Vanda Marques; João Vaz; Salma Awam; Marta B. Afonso; Maria Jesus Perry; Cecília MP Rodrigues. "Monocarbonyl Analogs of Curcumin with Potential to Treat Colorectal Cancer". Chemistry & Biodiversity (2023): https://doi.org/10.1002/cbdv.202300222.
  2. MJ Perry; Jacinta O. Pinho; Mariana Matias; Vanda Marques; Carla Eleutério; Célia Fernandes; Lurdes Gano; et al. "Preclinical validation of a new hybrid molecule loaded in liposomes for melanoma management". Biomedicine & Pharmacotherapy 157 (2023): 114021-114021. http://dx.doi.org/10.1016/j.biopha.2022.114021.
  3. Pinho, Jacinta O.; Matias, Mariana; Godinho-Santos, Ana; Amaral, Joana D.; Mendes, Eduarda; Perry, Maria Jesus; Francisco, Ana Paula; Rodrigues, Cecilia M. P.; Gaspar, M. Manuela. "A step forward on the in vitro and in vivo assessment of a novel nanomedicine against melanoma". International Journal of Pharmaceutics (2023): https://publons.com/wos-op/publon/61305611/.
  4. Capela, Rita; Felix, Rita; Clariano, Marta; Nunes, Diogo; Perry, Maria de Jesus; Lopes, Francisca. "Target Identification in Anti-Tuberculosis Drug Discovery". International Journal of Molecular Sciences (2023): https://publons.com/wos-op/publon/62287065/.
  5. Margarida Granada; Eduarda Mendes; Maria Jesus Perry; Maria João Penetra; Maria Manuela Gaspar; Jacinta O. Pinho; Sofia Serra; Catarina Teixeira António; Ana Paula Francisco. "Sulfur Analogues of Tyrosine in the Development of Triazene Hybrid Compounds: A New Strategy against Melanoma". ACS Medicinal Chemistry Letters (2021): https://doi.org/10.1021/acsmedchemlett.1c00252.
  6. "Discovery of a Necroptosis Inhibitor Improving Dopaminergic Neuronal Loss after MPTP Exposure in Mice". International Journal of Molecular Sciences 22 10 (2021): 5289-5289. http://dx.doi.org/10.3390/ijms22105289.
  7. Carrola, Joana; Duarte, Noélia; Florindo, Pedro; Henriques, Sara; da Silva, Gustavo; Bijlsma, Lubertus; Moreira, Rui; et al. "Metabolism of N-ethylhexedrone and buphedrone: An in vivo study in mice using HPLC-MS/MS". Journal of Chromatography B 1159 (2020): 122340. http://dx.doi.org/10.1016/j.jchromb.2020.122340.
    Published • 10.1016/j.jchromb.2020.122340
  8. Francisco, Ana P.; Mendes, Eduarda; Santos, Ana R.; Perry, Maria J.. "Anticancer Triazenes: from Bioprecursors to Hybrid Molecules". Current Pharmaceutical Design 25 14 (2019): 1623-1642. http://dx.doi.org/10.2174/1381612825666190617155749.
    Published • 10.2174/1381612825666190617155749
  9. Cláudia Braga; Ana R. Vaz; M. Conceição Oliveira; M. Matilde Marques; Rui Moreira; Dora Brites; Maria J. Perry. "Targeting gliomas with triazene-based hybrids: Structure-activity relationship, mechanistic study and stability". European Journal of Medicinal Chemistry 172 (2019): 16-25. https://doi.org/10.1016/j.ejmech.2019.03.048.
  10. Capela, R.; Magalhães, J.; Miranda, D.; Machado, M.; Sanches-Vaz, M.; Albuquerque, I.S.; Sharma, M.; et al. "Endoperoxide-8-aminoquinoline hybrids as dual-stage antimalarial agents with enhanced metabolic stability". European Journal of Medicinal Chemistry 149 (2018): 69-78. http://www.scopus.com/inward/record.url?eid=2-s2.0-85042651839&partnerID=MN8TOARS.
  11. Sousa, A.; Santos, F.; Gaspar, M.M.; Calado, S.; Pereira, J.D.; Mendes, E.; Francisco, A.P.; Perry, M.J.. "The selective cytotoxicity of new triazene compounds to human melanoma cells". Bioorganic and Medicinal Chemistry 25 15 (2017): 3900-3910. http://www.scopus.com/inward/record.url?eid=2-s2.0-85020296185&partnerID=MN8TOARS.
  12. Pinheiro, R.; Braga, C.; Santos, G.; Bronze, M.R.; Perry, M.J.; Moreira, R.; Brites, D.; Falcão, A.S.. "Targeting Gliomas: Can a New Alkylating Hybrid Compound Make a Difference?". ACS Chemical Neuroscience 8 1 (2017): 50-59. http://www.scopus.com/inward/record.url?eid=2-s2.0-85013797326&partnerID=MN8TOARS.
  13. Perry, MJ. "Nanoformulations of a Triazene Analogue with Specific Affinity to Human Melanoma.". J Nanosci Adv Tech, 1 (4) pp 1-9 (2016):
  14. Rodrigues, C.A.B.; Frade, R.F.M.; Albuquerque, I.S.; Perry, M.J.; Gut, J.; Machado, M.; Rosenthal, P.J.; et al. "Targeting the erythrocytic and liver stages of malaria parasites with s-triazine-based hybrids". ChemMedChem 10 5 (2015): 883-890. http://www.scopus.com/inward/record.url?eid=2-s2.0-84928476505&partnerID=MN8TOARS.
  15. Pereira, N.A.L.; Monteiro, Â.; Machado, M.; Gut, J.; Molins, E.; Perry, M.J.; Dourado, J.; et al. "Enantiopure Indolizinoindolones with in vitro Activity against Blood- and Liver-Stage Malaria Parasites". ChemMedChem 10 12 (2015): 2080-2089. http://www.scopus.com/inward/record.url?eid=2-s2.0-84951573479&partnerID=MN8TOARS.
  16. Oliveira, R.; Miranda, D.; Magalhães, J.; Capela, R.; Perry, M.J.; O'Neill, P.M.; Moreira, R.; Lopes, F.. "From hybrid compounds to targeted drug delivery in antimalarial therapy". Bioorganic and Medicinal Chemistry 23 16 (2015): 5120-5130. http://www.scopus.com/inward/record.url?eid=2-s2.0-84938951204&partnerID=MN8TOARS.
  17. Perry, MJ. "Design and discovery of mushroom tyrosinase inhibitors and their therapeutic applications.". Expert Opinion Drug Discovery, 2014. (5) 533-54. (2014):
  18. Blaszczak-Swiatkiewicz, K.; Almeida, D.C.; De Jesus Perry, M.; Mikiciuk-Olasik, E.. "Synthesis, anticancer activity and UPLC analysis of the stability of some New Benzimidazole-4,7-dione derivatives". Molecules 19 1 (2014): 400-413. http://www.scopus.com/inward/record.url?eid=2-s2.0-84893065343&partnerID=MN8TOARS.
  19. Monteiro, A.S.; Almeida, J.; Cabral, G.; Severino, P.; Videira, P.A.; Sousa, A.; Nunes, R.; et al. "Synthesis and evaluation of N-acylamino acids derivatives of triazenes. Activation by tyrosinase in human melanoma cell lines". European Journal of Medicinal Chemistry 70 (2013): 1-9. http://www.scopus.com/inward/record.url?eid=2-s2.0-84885368654&partnerID=MN8TOARS.
  20. Carmo Carreiras, M.; Mendes, E.; Jesus Perry, M.; Francisco, A.P.; Marco-Contelles, J.. "The multifactorial nature of Alzheimer's disease for developing potential therapeutics". Current Topics in Medicinal Chemistry 13 15 (2013): 1745-1770. http://www.scopus.com/inward/record.url?eid=2-s2.0-84887972850&partnerID=MN8TOARS.
  21. Carmo Carreiras, M.; Mendes, Eduarda; Jesus Perry, M.; Francisco, Ana Paula; Marco-Contelles, J.. "The Multifactorial Nature of Alzheimer's Disease for Developing Potential Therapeutics". Current Topics in Medicinal Chemistry (2013): https://publons.com/wos-op/publon/3570010/.
  22. Capucha, V.; Mendes, E.; Francisco, A.P.; Perry, M.J.. "Development of triazene prodrugs for ADEPT strategy: New insights into drug delivery system based on carboxypeptidase G2 activation". Bioorganic and Medicinal Chemistry Letters 22 22 (2012): 6903-6908. http://www.scopus.com/inward/record.url?eid=2-s2.0-84867847410&partnerID=MN8TOARS.
  23. Perry, M.d.J.; Carvalho, E.; Rosa, E.; Iley, J.. "Towards an efficient prodrug of the alkylating metabolite monomethyltriazene: Synthesis and stability of N-acylamino acid derivatives of triazenes". European Journal of Medicinal Chemistry 44 3 (2009): 1049-1056. http://www.scopus.com/inward/record.url?eid=2-s2.0-60549095830&partnerID=MN8TOARS.
  24. Perry, M.J.; Mendes, E.; Simplício, A.L.; Coelho, A.; Soares, R.V.; Iley, J.; Moreira, R.; Francisco, A.P.. "Dopamine- and tyramine-based derivatives of triazenes: Activation by tyrosinase and implications for prodrug design". European Journal of Medicinal Chemistry 44 8 (2009): 3228-3234. http://www.scopus.com/inward/record.url?eid=2-s2.0-67349149632&partnerID=MN8TOARS.
  25. "Anticancer Therapeutics". ANTICANCER THERAPEUTICS (2008): https://publons.com/wos-op/publon/3570014/.
  26. Carvalho, E.; Iley, J.; Perry, M.D.J.; Rosa, E.. "Triazene drug metabolites. Part 16.1 Kinetics and mechanism of the hydrolysis of aminoacyltriazenes". Journal of the Chemical Society. Perkin Transactions 2 11 (1998): 2375-2380. http://www.scopus.com/inward/record.url?eid=2-s2.0-0342738340&partnerID=MN8TOARS.
  27. Carvalho, E.; Iley, J.; De Jesus Perry, M.; Rosa, E.. "Triazene drug metabolites: Part 15. Synthesis and plasma hydrolysis of anticancer triazenes containing amino acid carriers". Pharmaceutical Research 15 6 (1998): 931-935. http://www.scopus.com/inward/record.url?eid=2-s2.0-0031750508&partnerID=MN8TOARS.
  28. Burgess, J.; De Perry, M.J.; Rosa, E.; Iley, J.. "The carbohydrate-catalysed hydrolysis of cephalosporins". Journal of the Chemical Society, Perkin Transactions 2 1 (1994): 97-101. http://www.scopus.com/inward/record.url?eid=2-s2.0-37049070891&partnerID=MN8TOARS.
  29. "The carbohydrate-catalysed hydrolysis of cephalosporins". Journal of the Chemical Society, Perkin Transactions 2 (1994): https://publons.com/wos-op/publon/3570011/.
Thesis / Dissertation
  1. "Desenvolvimento de Pró-fármacos de Triazenos Antitumorais Usando Amino-ácidos Como Transportadores". PhD, Universidade de Lisboa, 2003.